文献速递胃肠动力与功能性疾病

随机临床试验:个体与团体催眠疗法治疗肠易激综合征的比较

Randomised clinical trial: individual versus group hypnotherapy for irritable bowel syndrome.
PubMed 文献 · Aliment Pharmacol Ther · 2022-05-03

该随机临床试验将119例肠易激综合征患者随机分配至护士实施的个体催眠治疗(61例)或团体催眠治疗(58例),疗程8次共12周。两组IBS症状严重程度均较基线显著改善,个体组中位数从332降至216,团体组从315降至217,组间无差异(p=0.16)。结论认为团体催眠治疗可作为有效替代方案,使更多患者获益。

要点

  • 护士实施的个体或团体肠道导向催眠治疗均能显著改善IBS症状(p<0.0001)。
  • 个体组与团体组在IBS症状改善上无显著差异(p=0.16)。
  • 个体组应答率69% vs 团体组57%(p=0.25),差异未达统计学显著。

核心结论

  • 护士实施的个体或团体肠道导向催眠治疗均可缓解IBS症状,改善心理症状与生活质量。
  • 团体催眠治疗可作为有效替代方案,使更多患者受益。

研究设计与样本

  • 随机临床试验,119例IBS患者随机分配至个体催眠治疗(61例)或团体催眠治疗(58例)。
  • 干预为护士实施的8次治疗,共12周。

主要发现

  • 个体组IBS-SSS中位数从332(IQR 273-401)降至216(IQR 140-308),p<0.0001;团体组从315(IQR 239-382)降至217(IQR 149-314),p<0.0001。
  • 组间IBS症状改善无显著差异(p=0.16)。
  • 个体组治疗结束时应答者占69%,团体组占57%(p=0.25)。
  • 肠外症状、心理症状及生活质量均改善,组间无明确差异。
  • 治疗开始后6个月随访时仍可见症状改善。

关键数值与推荐

  • 应答定义为治疗结束时IBS严重程度评分系统(IBS-SSS)较基线降低≥50分。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Gut-directed hypnotherapy improves symptoms for patients with irritable bowel syndrome (IBS). Group hypnotherapy, as well as hypnotherapy administered by nurses, can increase treatment availability, but there are few comparisons between individual and group-based hypnotherapy. AIM: We aimed to evaluate and compare the effectiveness of nurse-administered hypnotherapy for IBS delivered individually or in groups. METHODS: IBS patients were randomised to individual or group hypnotherapy (8 sessions, 12 weeks). The primary endpoint was changes in severity of IBS symptoms. A responder was defined as reduction of IBS severity scoring system (IBS-SSS) ≥50 points at the end of treatment compared to baseline. The effects on extracolonic and psychological symptoms, and quality of life were also assessed. Symptoms were also followed up 6 months after treatment start. RESULTS: A total of 119 patients were randomised (61 individual, 58 group hypnotherapy). Patients reported improvements in IBS symptoms (IBS-SSS) (individual: 332 (273-401) (median, IQR), versus 216 (140-308), (p < 0.0001), group: 315 (239-382), versus 217 (149-314), (p < 0.0001)), with no differences between the groups (p = 0.16). Extracolonic symptoms, psychological symptoms and quality of life also improved, without clear differences between the groups. Sixty-nine percent of the individual hypnotherapy patients were responders after treatment versus 57% of the group hypnotherapy patients (p = 0.25). Symptom improvements were also seen at follow-up. CONCLUSIONS: Nurse-administered gut-directed hypnotherapy, delivered individually or in groups, relieves IBS symptoms, improves psychological symptoms and quality of life. Group hypnotherapy can be an efficacious alternative, enabling more patients to benefit from the treatment (ClinicalTrials.gov ID no of study: NCT03432078). Significant improvements regarding IBS symptoms were seen for patients receiving individual or group hypnotherapy, with no differences between the groups.[Image: see text]

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Lövdahl J, Törnblom H, Ringström G, et al. Randomised clinical trial: individual versus group hypnotherapy for irritable bowel syndrome. Aliment Pharmacol Ther. 2022. PMID: 35505463. doi:10.1111/apt.16934

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。